These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. In vitro and in vivo evaluation of the subtype-selective muscarinic agonist PD 151832. Jaen J; Barrett S; Brann M; Callahan M; Davis R; Doyle P; Eubanks D; Lauffer D; Lauffer L; Lipinski W Life Sci; 1995; 56(11-12):845-52. PubMed ID: 10188784 [TBL] [Abstract][Full Text] [Related]
7. Preclinical and phase 1 clinical characterization of CI-979/RU35926, a novel muscarinic agonist for the treatment of Alzheimer's disease. Sedman AJ; Bockbrader H; Schwarz RD Life Sci; 1995; 56(11-12):877-82. PubMed ID: 10188788 [TBL] [Abstract][Full Text] [Related]
8. Lithocholylcholine, a bile acid/acetylcholine hybrid, is a muscarinic receptor antagonist. Cheng K; Khurana S; Chen Y; Kennedy RH; Zimniak P; Raufman JP J Pharmacol Exp Ther; 2002 Oct; 303(1):29-35. PubMed ID: 12235229 [TBL] [Abstract][Full Text] [Related]
9. In vitro effects of organophosphorus anticholinesterases on muscarinic receptor-mediated inhibition of acetylcholine release in rat striatum. Liu J; Chakraborti T; Pope C Toxicol Appl Pharmacol; 2002 Jan; 178(2):102-8. PubMed ID: 11814330 [TBL] [Abstract][Full Text] [Related]
10. The M1 Muscarinic Positive Allosteric Modulator PQCA Improves Performance on Translatable Tests of Memory and Attention in Rhesus Monkeys. Lange HS; Cannon CE; Drott JT; Kuduk SD; Uslaner JM J Pharmacol Exp Ther; 2015 Dec; 355(3):442-50. PubMed ID: 26446308 [TBL] [Abstract][Full Text] [Related]
13. Effects of acute acetylcholinesterase inhibition on the cerebral cholinergic neuronal system and cognitive function: Functional imaging of the conscious monkey brain using animal PET in combination with microdialysis. Tsukada H; Nishiyama S; Fukumoto D; Ohba H; Sato K; Kakiuchi T Synapse; 2004 Apr; 52(1):1-10. PubMed ID: 14755627 [TBL] [Abstract][Full Text] [Related]
14. Correlation of the anticholinesterase activity of a series of organophosphates with their ability to compete with agonist binding to muscarinic receptors. Ward TR; Ferris DJ; Tilson HA; Mundy WR Toxicol Appl Pharmacol; 1993 Oct; 122(2):300-7. PubMed ID: 8212012 [TBL] [Abstract][Full Text] [Related]
16. Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosapride. Matsunaga Y; Tanaka T; Yoshinaga K; Ueki S; Hori Y; Eta R; Kawabata Y; Yoshii K; Yoshida K; Matsumura T; Furuta S; Takei M; Tack J; Itoh Z J Pharmacol Exp Ther; 2011 Mar; 336(3):791-800. PubMed ID: 21123674 [TBL] [Abstract][Full Text] [Related]
17. Preclinical to Human Translational Pharmacology of the Novel M Uslaner JM; Kuduk SD; Wittmann M; Lange HS; Fox SV; Min C; Pajkovic N; Harris D; Cilissen C; Mahon C; Mostoller K; Warrington S; Beshore DC J Pharmacol Exp Ther; 2018 Jun; 365(3):556-566. PubMed ID: 29563325 [TBL] [Abstract][Full Text] [Related]
19. Near-complete adaptation of the PRiMA knockout to the lack of central acetylcholinesterase. Farar V; Mohr F; Legrand M; Lamotte d'Incamps B; Cendelin J; Leroy J; Abitbol M; Bernard V; Baud F; Fournet V; Houze P; Klein J; Plaud B; Tuma J; Zimmermann M; Ascher P; Hrabovska A; Myslivecek J; Krejci E J Neurochem; 2012 Sep; 122(5):1065-80. PubMed ID: 22747514 [TBL] [Abstract][Full Text] [Related]
20. The scopolamine-reversal paradigm in rats and monkeys: the importance of computer-assisted operant-conditioning memory tasks for screening drug candidates. Buccafusco JJ; Terry AV; Webster SJ; Martin D; Hohnadel EJ; Bouchard KA; Warner SE Psychopharmacology (Berl); 2008 Aug; 199(3):481-94. PubMed ID: 17657478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]